Literature DB >> 15942493

Acquired lower eyelid epiblepharon in patients with thyroid eye disease.

Eli L Chang1, Jasmine Hayes, Mark Hatton, Peter A D Rubin.   

Abstract

PURPOSE: To describe a series of patients with acquired epiblepharon secondary to thyroid-related orbitopathy.
METHODS: Retrospective case series of 9 patients with thyroid-related orbitopathy who had epiblepharon.
RESULTS: Seven patients had epiblepharon in both lower eyelids and 2 patients had it in one lower eyelid. Six of the 9 patients were Asian. Each patient had punctate keratopathy. Epiblepharon resolved in all but one patient after treating coexisting manifestations of thyroid-related orbitopathy. One patient required epiblepharon repair.
CONCLUSIONS: We describe a new finding of acquired epiblepharon in the setting of thyroid-related orbitopathy. The majority of patients have spontaneous resolution of the epiblepharon after other surgical procedures for thyroid-related orbitopathy.

Entities:  

Mesh:

Year:  2005        PMID: 15942493     DOI: 10.1097/01.iop.0000160597.59156.79

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  4 in total

1.  Lower eyelid epiblepharon associated with lower eyelid retraction.

Authors:  Mi Sun Sung; Min Joung Lee; Ho-Kyung Choung; Nam Ju Kim; Sang In Khwarg
Journal:  Korean J Ophthalmol       Date:  2010-02-05

2.  Acquired Epiblepharon Treated by Lateral Orbital and fat Decompression.

Authors:  Radwan Almousa; Gangadhara Sundar
Journal:  Middle East Afr J Ophthalmol       Date:  2011-01

3.  Thyroid Eye Disease-Related Epiblepharon: A Comparative Case Study.

Authors:  Jiawei Zhao; Nickisa M Hodgson; Jessica R Chang; Ashley A Campbell; Timothy J McCulley
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2020 Jan-Feb

4.  Outcomes of various surgical procedures on acquired lower eyelid epiblepharon in thyroid associated ophthalmopathy.

Authors:  Sung Wook Park; Namju Kim; Ho-Kyung Choung; Sang In Khwarg
Journal:  Korean J Ophthalmol       Date:  2012-09-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.